Genesis Healthcare (GEN) closed the newest buying and selling day at $1.38, shifting +0.01% from th
Genesis Healthcare (GEN) closed the newest buying and selling day at $1.38, shifting +0.01% from the earlier buying and selling session. This transformation lagged the S&P 500’s 0.41% acquire on the day. Elsewhere, the Dow gained 0.57%, whereas the tech-heavy Nasdaq added 0.7%.
Coming into in the present day, shares of the operator of nursing houses and senior residing communities had gained 30.19% prior to now month. In that very same time, the Medical sector misplaced 0.65%, whereas the S&P 500 gained 2.04%.
Buyers will likely be hoping for energy from GEN because it approaches its subsequent earnings launch. On that day, GEN is projected to report earnings of -$0.10 per share, which might signify year-over-year progress of 68.75%. In the meantime, the Zacks Consensus Estimate for income is projecting web gross sales of $1.13 billion, down 7.17% from the year-ago interval.
GEN’s full-year Zacks Consensus Estimates are calling for earnings of -$0.46 per share and income of $4.55 billion. These outcomes would signify year-over-year modifications of +70.32% and -8.6%, respectively.
…